# Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-19 12:29 UTC · Category: Business · Sources: 11 · Current Velocity: 10.78

## Executive Summary
Moderna shares surged following trial results for a personalized mRNA melanoma vaccine developed with Merck.

## Intelligence Brief
The treatment helped cut melanoma recurrence, described by coverage as a potential landmark moment for cancer treatment and skin-cancer vaccine development. Coverage emphasizes the involvement of both companies and the specific focus on preventing the recurrence of melanoma.


Coverage does not yet specify the full timeline for regulatory approval or commercial availability, nor do the headlines establish what future steps the companies will take with the vaccine data.

## Verified Facts & Key Claims
### Which companies developed the melanoma vaccine?
Moderna and Merck developed the personalized mRNA melanoma vaccine.

### What type of trial did the vaccine succeed in?
The vaccine succeeded in a large, late-stage trial for melanoma.

### What effect did the shot have on patients?
The shot helped cut melanoma recurrence and showed promise in preventing the return of the disease.

## Key People, Organizations & Locations
Cancer, Merck, Moderna, Moderna and Merck, Moderna-Merck MRNA Shot Helped Cut Melanoma Recurrence, Big Trial, Personalized, Moderna Merck

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| The New York Times | Moderna’s Shift to Cancer Company Lifts Stock Up 177% | 2026-08-20 04:28 | [Source Link](https://news.google.com/rss/articles/CBMifEFVX3lxTE5OWGhUMUI1SFZkUzBhUVBFQUVGRkZxYjl2ZDFsY2pZajhUQXNMMU1Xd2Z2ZU04R09MYTAzZXlmOXFZSU1nV1FsMXJkamE4eU9yUXJHRGtQNV81cnVVT1diSUk2ZXZ1Zi1RUEtpVGNfN0NubWxjTmFNejA5R1E?oc=5) |
| Yahoo Finance | Why Did MRNA, MRK, TGT Stocks Jump To 52-Week Highs Today? | 2026-08-20 01:28 | [Source Link](https://news.google.com/rss/articles/CBMijgFBVV95cUxNcHhIR0YzSUNxak1wS2JsOURjdDNPNFJnUzZDU3FpOFVnUDRmQjZLNDZ4bDVGczE5c29ud2dNaVMwNGdkbklORGZkZmhGZmVkdE9FVE9QMFZhdFlTbFQ3dUFLOW9PNWxDQ2hJSXFrMHRvSVV0bzd5Y1Z3UVEzNzBFUnJGZzIyVXBRWWxHZmR3?oc=5) |
| Yahoo Finance | Moderna stock surges as melanoma vaccine trial shows "landmark moment" | 2026-08-19 16:53 | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxOazdJUUtBR0hoR09hblpCblZSQ0oxeS14WXNOcnA0RG90UjRWc2JNZU1LVi1oVU8wT3V3VnQ0WlVlZUdTTFJXdnAxNXNMZ1pLVFQ2ejVsX3hsSVNkM0hsTWEyUHBIUTdObXVjMHlZdml1N2s3SWJCWUVBM25Sa0pPS0VoSmZzX3J4RS1SQThEck5ydGFLa2tickhfdHg2THM?oc=5) |
| Bloomberg.com | Moderna’s 160% Surge Burns Shorts in ‘Painful’ $5 Billion Loss | 2026-08-19 16:53 | [Source Link](https://news.google.com/rss/articles/CBMirgFBVV95cUxNeTJWbHpCcW54aDJhQUdpMjRsbWo2bFhkSFdqZElOLVc3WDM1bTlaSUZDTDUwUmxRT192MllqZlpkOXhYYVhZZk9ZR2l0bnV2R2hwWndsZUt5N3d2QUwzN1lBSGFESG9aRmg4RTdOMjV5dnhaTFU5dzZ4U2UwNVRWTnZFYmlvQmNTT3JyYl8yQWNhWHdhZ0ZqQlhGdEdiNlBwT1dQZ3ViQS1LWFBoVWc?oc=5) |
| WSJ | mRNA Vaccine Stocks Rise on Moderna-Merck Success | 2026-08-19 16:53 | [Source Link](https://news.google.com/rss/articles/CBMi7AFBVV95cUxNMHBIb0REazdmVkRtczNkLTQyQjlERG52VGtrN1ZLY0loYk16Q2ZiSXVxb3JNdU9zUlJvb0ZoQkowNHVGaHF0XzJLclNMZnpVODVDTDhsQjhnRE5yQnVvZk1fMzd5ZnlkUHQ3WE5fYmdWRW85cDJuRjNxMEdDd2xBRUI4WjZ6Y2pTNkpma19ud3hWd0wyV1pGSUpuM19LdHFvWGlza0xVZ0xPaVVqc1pjYkhST0g0Z2p0X1ZnUXRMZWxaZll3X3JQSmg4QW9tUDc5dDZnWWNJWGE2YTJ2OE50eDktWnZrbjEtTS1BYg?oc=5) |
| Ars Technica | mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say | 2026-08-19 16:53 | [Source Link](https://news.google.com/rss/articles/CBMiuAFBVV95cUxORkVfMUhaUFhZaU05Z0RhVmc3S3VEamptbWVPZmdCaUVJR0RDV2l3d2g4NzFkVXI4alZfSHdMZnpjTE5TVkpYbU9PX0M5blRaQjVIb3RRZ2xMcHVEeG9rdDVSR1VJdENralpYUmxTa2lIbDVESUc0ZDd3bHpGcWs1VzIxMWt5NnhsWVJrZV9mQmtERnM5RWEzWXFDdDNjTTBtYzAtYXdIVXRBaUo2ak5scXRHcVJ1cXpj?oc=5) |
| CNN | Moderna shares surge as melanoma vaccine with Merck succeeds in large trial | 2026-08-19 10:49 | [Source Link](https://news.google.com/rss/articles/CBMifkFVX3lxTE5rdk1JZHNYak56OXBuQ1JlcjdfM3FOdTJEUEJ1UXJ5Ri1yOGxjNWQwZWF0VGw0emZ6dFlsS2VYc1lYTkl3QjBQeWVvOWpOcE1MazVPY1NBZjgtR0tQZndfS1BCQjhvUEM5MWZaV0dKb3AtQi11S1NEZXJRcXo3QQ?oc=5) |
| The Washington Post | Cancer treatment could face landmark moment with promising vaccine | 2026-08-19 10:49 | [Source Link](https://news.google.com/rss/articles/CBMitwFBVV95cUxPMWdlVzZuZWlXalBPN1IzRnpmWDZGeDdPOEFzdkZlRWNyY3EtajQ5aW55SFl0VVZYc2hlRXBtRG85dzdONHNlTWd2eHlqUVBRTUlmNEprVnJFOHpQbGRsSl9wYUFYZ1lFVGxNeXNmc1doR3c0Mm1YMGlLVzI5Qlo4TnRZRTBaV0JoUFh6MHZfWE9Ha2RhV2k0T2N3Rkhld1RqNkk3MWVFVzJCUHhVbnoyd3dXNmZheTg?oc=5) |
| Bloomberg.com | Moderna-Merck MRNA Shot Helped Cut Melanoma Recurrence in Big Trial | 2026-08-19 10:49 | [Source Link](https://news.google.com/rss/articles/CBMiugFBVV95cUxQd20xaU5VWlNmQmgwVVJ0R0FxS2kxWUhPYmhJMzZ2NzJ6WTVKWG4xcGxjSHdRSlEtZHlRZUd0dUt6R0lHQldrYTNERkM0Qmd3ZHJlVW9ZQWNYN29vQU9iaTNaVk9wNEg3di1WZGQ1YnU1Z1N3XzI5SklTMTBrdEI0ZUN6c3hyblBYcmloeXVSbk1FaEJhT2ZHYXltOGRCdEdkSkVhRmRFY1UzbEJ2ZVg5Z3d1enkzVGMtRnc?oc=5) |
| CNBC | Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial | 2026-08-19 10:49 | [Source Link](https://news.google.com/rss/articles/CBMipwFBVV95cUxOUlktR2pLY0JiWFdHWWtNb2ozX2ltdUZPV0F3SlNud0o5aUF0Nk16bEZjTU9yWW1sd044bnlwYWxrM0pGaDE5TGRQS2hlWGNtbVJIOF8zNVpQOWF5S1FMUXdCeV85Y1oxOG9Dck9ydjZGcGN2czgxOE5aeFY5Y3BVVExITTZpY1JUbG9sMHYtZmpCRzZGa1dGNUJBR0JvTl9TRmZ6R0NxSdIBrAFBVV95cUxNSDhhdThuTXRTbkNHRzIzVklfb3M0S1pjWWFSNTBhal9GQlVWZzBZVkpDeEVlREc2eEYyNTRNSkdvSzZ3cVBQanc3S012LWZocFVoTXJNMHVJaHFNSFBlZG1vMFZ3eTk0NzhSUEdXSGR4QXY5N1o5Q1FPN3czNTFHOURrektERU02MFQxRmMtTDJrNFhDeEE5OHBFVHBHRzRCeGZZNjBjV3BNZmV) |
| STAT | Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial | 2026-08-19 10:49 | [Source Link](https://news.google.com/rss/articles/CBMijgFBVV95cUxNOVJjTGRvUDNjbXM4NFZtdENhQU5pRDRsV0F1dnctNGRhVEJPbTZuWFBRZ3huTnhIT2o0SjZwTXQ4WmZGSF82V0VQLUQ3dEV0RWdKVDMyZXRoQVFlRFRXMXBVSXl5RzlDUmUyTFJXWDdJb0FJaVBGbW5jRTBYdTEtNnBZX2VLcFZjSDZubjdR?oc=5) |
| The Economist | World in Brief: trials show promise for a skin-cancer vaccine; Trump pauses Canada tariffs | 2026-08-19 10:46 | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxQV2dBaGQzenZTd2hqNE5UMHVnMjVaVVBUUVVESFBOZXEzTkhBUl9GeUhNZmF1Z3JwZTZIckg1dUtfRE1rZmNOdmM5M2tBUmNrN1dzZ2x2cjZJajZlSnVvNjJrWlBTUkFwZG1VUXZWTWd2dW5Eb3dUYW10eXpuY0FNN2FHNDQ3MmY5aDVjUFpkSk1Rd1BxUnBB?oc=5) |
| NBC News | Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma | 2026-08-19 10:46 | [Source Link](https://news.google.com/rss/articles/CBMivwFBVV95cUxOSGR4cnJhdGF4MkVpcU9yanlWZUpFVDd6SzJpSTVGR2tJT28zd2JxYmpKOTdXU0VpSjA1aFRVNzd6c0lCU0d0TFJ4WWxqdDE0Ml95UmFBVTR2Q3lnZ3NuRGZwc1FBVDJGeUhGemxGZTRjWExhWkd3SERWTXJNZXNfWnJXUFZSeDMzRGxVdWlKQ3VRU196WDRvaEVIRHhjT2RRSUpzWHlRdTBKeHI5MzRaSG9iVy1uZENBR3lhNWlVRQ?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-19/moderna-and-merck-say-mrna-cancer-vaccine-succeeded-in-late-stage-melanoma-trial*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*